Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluoxetine for Visual Recovery After Ischemic Stroke

NCT02737930 is registered in ClinicalTrials.gov with Bogachan Sahin as lead sponsor.

NCT NCT02737930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02737930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluoxetine for Visual Recovery After Ischemic Stroke
Lead sponsor
Bogachan Sahin
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2016
Completion date
August 31, 2020
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, visual field loss